Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: COPD Age: Adults Condition: Maintenance therapy |
Dose: Convicap – 200 mcg Frequency: 2 capsules twice daily |
|
Indication: COPD Age: Adults Condition: Maintenance therapy |
Dose: Convicap – 400 mcg Frequency: 1 capsule twice daily |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: less than 12 years |
Dose: Not applicable Note: Safety and efficacy not established |
|
Indication: COPD Age: 12 years and older Condition: Maintenance therapy |
Dose: Convicap – 200 mcg Frequency: 2 Convicaps twice daily |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment |
Dose: Budesonide + Formoterol Fumarate Note: Formal pharmacokinetic studies using Budesonide + Formoterol Fumarate have not been conducted in patients with renal impairment. |
Administration
- Can be taken with or without food
- Shake inhaler well before each use
Side Effect
- Upper respiratory tract infection (URTI) (URTI) (8-11%)
- Headache (7-11%)
- Nasopharyngitis (7-11%)
- Pharyngolaryngeal pain (6-9%)
- Stomach discomfort (1-7%)
- Sinusitis (5-6%)
- Oral candidiasis (1-6%)
- Bronchitis (5%)
- Viral URTI (4%)
- Backache (2-3%)
- Influenza (2-3%)
- Nasal congestion (2-3%)
- Vomiting (1- 3%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP3A4 inhibitors
|
May inhibit metabolism of budesonide
|
|
Non Potassium-sparing diuretics (Amiloride, Eplerenone, Spironolactone, Triamterene)
|
May lead to ECG changes and/or hypokalaemia
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Status Asthmaticus, Acute Episodes of Asthma
|
Not suitable for emergency treatment
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Protect from light, store in cool & dry place. Do not store above 30° C. Keep out of the reach of children. Protect from freezing.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.